Access the full text.
Sign up today, get DeepDyve free for 14 days.
P. Hagen, M. Hulshof, J. Lanschot, E. Steyerberg, M. Henegouwen, B. Wijnhoven, D. Richel, G. Nieuwenhuijzen, G. Hospers, J. Bonenkamp, M. Cuesta, R. Blaisse, O. Busch, F. Kate, G. Creemers, C. Punt, J. Plukker, H. Verheul, E. Bilgen, H. Dekken, M. Sangen, T. Rozema, K. Biermann, J. Beukema, A. Piet, C. rij, J. Reinders, H. Tilanus, A. Gaast (2012)Preoperative chemoradiotherapy for esophageal or junctional cancer.
The New England journal of medicine, 366 22
A Pennathur (2013)400
D. Dindo, N. Demartines, P. Clavien (2004)Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey
Annals of Surgery, 240
(2008)Japanese classification of esophageal cancer
P. Krarup, A. Nordholm-Carstensen, L. Jørgensen, H. Harling (2014)Anastomotic Leak Increases Distant Recurrence and Long-Term Mortality After Curative Resection for Colonic Cancer: A Nationwide Cohort Study
Annals of Surgery, 259
Y. Kanda (2012)Investigation of the freely available easy-to-use software ‘EZR' for medical statistics
Bone Marrow Transplantation, 48
L. Chirieac, S. Swisher, J. Ajani, R. Komaki, A. Correa, Jeffrey Morris, J. Roth, A. Rashid, S. Hamilton, Tsung-Teh Wu (2005)Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation
H. Kato, Y. Tachimori, Hiroshi Watanabe, H. Yamaguchi, T. Ishikawa, Y. Kagami (1997)Thoracic esophageal carcinoma above the carina: A more formidable adversary?
Journal of Surgical Oncology, 65
Y. Goldfarb, L. Sorski, M. Benish, B. Levi, R. Melamed, S. Ben-Eliyahu (2011)Improving Postoperative Immune Status and Resistance to Cancer Metastasis: A Combined Perioperative Approach of Immunostimulation and Prevention of Excessive Surgical Stress Responses
Annals of Surgery, 253
B. Burmeister, B. Smithers, V. Gebski, L. Fitzgerald, R. Simes, P. Devitt, S. Ackland, D. Gotley, D. Joseph, J. Millar, J. North, E. Walpole, J. Denham (2005)Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.
The Lancet. Oncology, 6 9
M. Yano, K. Takachi, Y. Doki, I. Miyashiro, K. Kishi, S. Noura, H. Eguchi, T. Yamada, M. Ohue, H. Ohigashi, Y. Sasaki, O. Ishikawa, S. Imaoka (2006)Preoperative chemotherapy for clinically node-positive patients with squamous cell carcinoma of the esophagus.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 19 3
K Kataoka, H Takeuchi, J Mizusawa (2017)Prognostic impact of postoperative morbidity after esophagectomy for esophageal cancer
Ann Surg., 265
T. Lerut, J. Moons, W. Coosemans, D. raemdonck, P. Leyn, H. Decaluwé, G. Decker, P. Nafteux (2009)Postoperative Complications After Transthoracic Esophagectomy for Cancer of the Esophagus and Gastroesophageal Junction Are Correlated With Early Cancer Recurrence: Role of Systematic Grading of Complications Using the Modified Clavien Classification
Annals of Surgery, 250
J. Tepper, M. Krasna, D. Niedzwiecki, D. Hollis, C. Reed, R. Goldberg, K. Kiel, C. Willett, D. Sugarbaker, R. Mayer (2008)Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 7
A. Jemal, F. Bray, Melissa Center, J. Ferlay, Elizabeth Ward, D. Forman (2011)Global cancer statistics
CA: A Cancer Journal for Clinicians, 61
S. Biere, K. Maas, M. Cuesta, D. Peet (2011)Cervical or Thoracic Anastomosis after Esophagectomy for Cancer: A Systematic Review and Meta-Analysis
Digestive Surgery, 28
K. Prenzel, A. König, P. Schneider, Christian Schnickmann, S. Baldus, W. Schröder, E. Bollschweiler, H. Dienes, R. Mueller, J. Izbicki, A. Hölscher (2007)Reduced Incidence of Nodal Micrometastasis after Major Response to Neoadjuvant Chemoradiation in Locally Advanced Esophageal Cancer
Annals of Surgical Oncology, 14
J Bancewicz, PI Clark, DB Smith (2002)Medical Research Council Oesophageal Cancer Working G. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomized controlled trial
Koji Tanaka, M. Yano, M. Motoori, K. Kishi, I. Miyashiro, T. Shingai, K. Gotoh, S. Noura, Hidenori Takahashi, M. Ohue, Terumasa Yamada, H. Ohigashi, Takashi Yamamoto, Tomoyuki Yamasaki, Y. Doki, O. Ishikawa (2010)CEA-Antigen and SCC-Antigen mRNA Expression in Peripheral Blood Predict Hematogenous Recurrence After Resection in Patients with Esophageal Cancer
Annals of Surgical Oncology, 17
S. Thies, R. Langer (2013)Tumor Regression Grading of Gastrointestinal Carcinomas after Neoadjuvant Treatment
Frontiers in Oncology, 3
S. Lagarde, J. Boer, F. Kate, O. Busch, H. Obertop, J. Lanschot (2008)Postoperative Complications After Esophagectomy for Adenocarcinoma of the Esophagus Are Related to Timing of Death Due to Recurrence
Annals of Surgery, 247
G. Dunn, L. Old, R. Schreiber (2004)The immunobiology of cancer immunosurveillance and immunoediting.
Immunity, 21 2
K. Kataoka, H. Takeuchi, J. Mizusawa, H. Igaki, S. Ozawa, T. Abe, Kenichi Nakamura, Ken Kato, N. Ando, Y. Kitagawa (2017)Prognostic Impact of Postoperative Morbidity After Esophagectomy for Esophageal Cancer: Exploratory Analysis of JCOG9907
Annals of Surgery, 265
D. Kelsen, K. Winter, L. Gunderson, J. Mortimer, N. Estes, D. Haller, J. Ajani, W. Kocha, B. Minsky, J. Roth, C. Willett (2007)Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 24
K. Yamashita, T. Makino, H. Miyata, Y. Miyazaki, Tsuyoshi Takahashi, Y. Kurokawa, M. Yamasaki, K. Nakajima, S. Takiguchi, M. Mori, Y. Doki (2016)Postoperative Infectious Complications are Associated with Adverse Oncologic Outcomes in Esophageal Cancer Patients Undergoing Preoperative Chemotherapy
Annals of Surgical Oncology, 23
G. Ma, D. Situ, Q. Ma, H. Long, Lan-Jun Zhang, P. Lin, T. Rong (2014)Three-field vs two-field lymph node dissection for esophageal cancer: a meta-analysis.
World journal of gastroenterology, 20 47
J Bancewicz (2002)1727
A Pennathur, MK Gibson, BA Jobe (2013)Oesophageal carcinoma
S. Khuri, W. Henderson, R. Depalma, Cecilia Mosca, N. Healey, D. Kumbhani (2005)Determinants of Long-Term Survival After Major Surgery and the Adverse Effect of Postoperative Complications
Annals of Surgery, 242
A. Mantovani, P. Allavena, A. Sica, F. Balkwill (2008)Cancer-related inflammation
J. Bosset, M. Gignoux, J. Triboulet, E. Tiret, G. Mantion, D. Elias, P. Lozach, J. Ollier, J. Pavy, M. Mercier, T. Sahmoud, P. Ségol, Jean-Bernard Flamant, J. Arnaud, J. Plachot, A. Mandard, G. Chaillard (1997)Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus.
The New England journal of medicine, 337 3
K. Zafirellis, A. Fountoulakis, K. Dolan, S. Dexter, I. Martin, H. Sue-Ling (2002)Evaluation of POSSUM in patients with oesophageal cancer undergoing resection
British Journal of Surgery, 89
Y. Kurokawa, T. Shibata, N. Ando, S. Seki, H. Mukaida, H. Fukuda (2013)Which is the Optimal Response Criteria for Evaluating Preoperative Treatment in Esophageal Cancer: RECIST or Histology?
Annals of Surgical Oncology, 20
N. Ando, H. Kato, H. Igaki, M. Shinoda, S. Ozawa, H. Shimizu, Tsutomu Nakamura, H. Yabusaki, N. Aoyama, A. Kurita, K. Ikeda, T. Kanda, T. Tsujinaka, Kenichi Nakamura, H. Fukuda (2011)A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907)
Annals of Surgical Oncology, 19
R. Langer, K. Ott, M. Feith, F. Lordick, J. Siewert, K. Becker (2009)Prognostic significance of histopathological tumor regression after neoadjuvant chemotherapy in esophageal adenocarcinomas
Modern Pathology, 22
Ch. Wittekind, M. Gospodarowicz, L. Sobin (2009)TNM Classification of Malignant Tumours, 7th Edition
Ann Surg Oncol (2018) 25:2034–2043 https://doi.org/10.1245/s10434-018-6504-8 O R I G IN AL ARTI CL E – GA STROIN TESTINA L O N C OLO G Y The Negative Survival Impact of Infectious Complications After Surgery is Canceled Out by the Response of Neoadjuvant Chemotherapy in Patients with Esophageal Cancer 1 2 1 2 Kazuki Kano, MD , Toru Aoyama, MD, PhD , Takaki Yoshikawa, MD, PhD , Yukio Maezawa, MD , 1 1 1 2 Tetsushi Nakajima, MD , Tsutomu Hayashi, MD , Takanobu Yamada, MD, PhD , Tsutomu Sato, MD, PhD , 2 2 2 1 Takashi Oshima, MD, PhD , Yasushi Rino, MD, PhD , Munetaka Masuda, MD, PhD , Haruhiko Cho, MD, PhD , and Takashi Ogata, MD, PhD 1 2 Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Kanagawa, Japan; Department of Surgery, Yokohama City University, Yokohama, Japan ABSTRACT interval [CI] 1.057–5.263, p = 0.036). In the subset anal- Background. This study was designed to investigate ysis, postoperative ICs were a marginally signiﬁcant whether postoperative infectious complications (ICs) are a independent risk factor for OS in the nonresponders (HR risk factor for the prognosis in esophageal cancer patients 2.862; 95% CI 0.942–8.696, p = 0.063) but
Annals of Surgical Oncology – Springer Journals
Published: May 10, 2018
Access the full text.
Sign up today, get DeepDyve free for 14 days.